Akari Therapeutics Sees Cost Savings Through Reduced Clinical Trial, Infrastructure Costs >AKTX
Akari Therapeutics Sees Cost Savings Through Reduced Clinical Trial, Infrastructure Costs >AKTX
Akari Therapeutics認爲,通過減少臨床試驗和基礎設施成本可以節省成本 >AKTX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊